2021
DOI: 10.1158/1078-0432.ccr-20-3807
|View full text |Cite
|
Sign up to set email alerts
|

Microbiome Analysis of More Than 2,000 NHS Bowel Cancer Screening Programme Samples Shows the Potential to Improve Screening Accuracy

Abstract: To assess the utility of microbiome profiles for national-scale colorectal cancer (CRC) screening, we assessed 2,252 routinely processed NHS Bowel Cancer Screening Programme guaiac faecal occult blood test (gFOBT) samples. We generated four microbiome-based random forest classification models, each showing potential to improve accuracy.Two distinguished either CRC or neoplasm (CRC or adenoma) from gFOBT blood-negative samples (equivalent to firsttier screening). Two distinguished CRC or neoplasm from samples t… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
17
1
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(20 citation statements)
references
References 67 publications
0
17
1
2
Order By: Relevance
“…A large number of studies that address the CRC microbial community composition have used fecal samples, prompted by their potential use as a non-invasive tool for cancer screening and early detection [ 20 , 21 ]. In fact, recent data collected in a national screening program suggest that microbial profiling may improve CRC screening accuracy [ 22 ]. However, while the use of fecal samples for microbiome studies may have advantages due to their ease of collection and non-invasive nature, their composition does not accurately represent the more stable cancer microbiota and the mucosal interactions across the gut [ 23 , 24 ].…”
Section: Introductionmentioning
confidence: 99%
“…A large number of studies that address the CRC microbial community composition have used fecal samples, prompted by their potential use as a non-invasive tool for cancer screening and early detection [ 20 , 21 ]. In fact, recent data collected in a national screening program suggest that microbial profiling may improve CRC screening accuracy [ 22 ]. However, while the use of fecal samples for microbiome studies may have advantages due to their ease of collection and non-invasive nature, their composition does not accurately represent the more stable cancer microbiota and the mucosal interactions across the gut [ 23 , 24 ].…”
Section: Introductionmentioning
confidence: 99%
“…For microbiome-derived biomarkers based on bacteria for the detection of early CRC, 26 articles were found and two articles were found investigating the co-metabolome solely as a biomarker. Seventeen of the studies were conducted in East Asia [ 19 , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] ], one in South Asia [43] , eight in Europe [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] and two in North America [ 52 , 53 ]. The number of inclusions of these studies ranged between 2 and 462 for CRC, 18 and 665 for adenoma and/or polyp and 24 and 788 for healthy controls.…”
Section: Resultsmentioning
confidence: 99%
“…Regarding the stage used in the articles for early CRC detection, five studies were based on stage I or II [ 29 , 30 , 37 , 40 , 50 ] and two used stage 0 [ 19 , 38 ]. The other studies investigated a precursor lesion of CRC, either advanced adenomas or polyps (AP) [ 28 , [31] , [32] , [33] , [34] , [35] , 39 , 41 , [44] , [45] , [46] , [47] , [48] , [49] , [51] , [52] , [53] ]. Only five articles evaluated both precursor lesions of CRC and stages I and II [ 27 , 36 , 38 , 43 , 54 ].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations